292 related articles for article (PubMed ID: 7749107)
21. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
[TBL] [Abstract][Full Text] [Related]
22. HLA-haploidentical umbilical cord blood stem cell transplantation in a child with advanced leukemia: clinical outcome and analysis of hematopoietic recovery.
Miniero R; Busca A; Roncarolo MG; Saitta M; Iavarone A; Timeus F; Biondi A; Amoroso A; Perugini L; Ciuti E
Bone Marrow Transplant; 1995 Aug; 16(2):229-40. PubMed ID: 7581141
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
[TBL] [Abstract][Full Text] [Related]
24. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
Beam D; Poe MD; Provenzale JM; Szabolcs P; Martin PL; Prasad V; Parikh S; Driscoll T; Mukundan S; Kurtzberg J; Escolar ML
Biol Blood Marrow Transplant; 2007 Jun; 13(6):665-74. PubMed ID: 17531776
[TBL] [Abstract][Full Text] [Related]
26. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
27. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
28. HLA-mismatched cord blood transplantation in a patient with advanced leukemia.
Vilmer E; Sterkers G; Rahimy C; Elion J; Broyart A; Lescoeur B; Gerota J; Loche M; Tiercy JM; Blot P
Bone Marrow Transplant; 1991; 7 Suppl 2():125. PubMed ID: 1678975
[No Abstract] [Full Text] [Related]
29. Unrelated, HLA-mismatched multiple human umbilical cord blood transfusion in four cases with advanced solid tumors: initial studies.
Shen BJ; Hou HS; Zhang HQ; Sui XW
Blood Cells; 1994; 20(2-3):285-92. PubMed ID: 7749108
[TBL] [Abstract][Full Text] [Related]
30. Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant.
Godder KT; Mehta J; Chiang KY; Adams S; van Rhee F; Singhal S; Higgins-Smith K; O'Neal W; DeRienzo S; Henslee-Downey JP
Bone Marrow Transplant; 2001 Dec; 28(11):1031-6. PubMed ID: 11781612
[TBL] [Abstract][Full Text] [Related]
31. Use of granulocyte-macrophage colony-stimulating factor in two children treated with cord blood transplantation.
Vowels MR; Tiedemann K; Lam-Po-Tang R; Tucker DP
Blood Cells; 1994; 20(2-3):249-54; discussion 254-5. PubMed ID: 7749102
[TBL] [Abstract][Full Text] [Related]
32. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
[TBL] [Abstract][Full Text] [Related]
33. Umbilical cord blood transplantation: overview of the clinical experience.
Wagner JE
Blood Cells; 1994; 20(2-3):227-33; discussion 233-4. PubMed ID: 7749099
[TBL] [Abstract][Full Text] [Related]
34. [Graft-versus-leukemia effect by lymphocytes from the first donor after second cord blood transplantation in a patient with T-lymphoblastic lymphoma].
Nagai K; Hashimoto H; Itoh K; Matsushita A; Shimoji S; Kimura T; Inoue D; Mori M; Nagai Y; Tabata S; Yanagida M; Takahashi T
Rinsho Ketsueki; 2010 Jun; 51(6):413-21. PubMed ID: 20622488
[TBL] [Abstract][Full Text] [Related]
35. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
37. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources.
Souillet G; Guffon N; Maire I; Pujol M; Taylor P; Sevin F; Bleyzac N; Mulier C; Durin A; Kebaili K; Galambrun C; Bertrand Y; Froissart R; Dorche C; Gebuhrer L; Garin C; Berard J; Guibaud P
Bone Marrow Transplant; 2003 Jun; 31(12):1105-17. PubMed ID: 12796790
[TBL] [Abstract][Full Text] [Related]
38. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results.
Rubinstein P; Stevens CE
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):565-84. PubMed ID: 11102277
[TBL] [Abstract][Full Text] [Related]
39. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
40. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
